Literature DB >> 32928703

Dapagliflozin Improves Left Ventricular Myocardial Longitudinal Function in Patients With Type 2 Diabetes.

Alexander Brown, Stephen Gandy, Ify R Mordi, Rory McCrimmon, Prasad G Ramkumar, J Graeme Houston, Allan D Struthers, Chim C Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32928703     DOI： 10.1016/j.jcmg.2020.07.025

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  3 in total

Review 1.  Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.

Authors:  Jonathan P Law; Luke Pickup; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Hum Hypertens       Date:  2022-09-22       Impact factor: 2.877

Review 2.  Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention.

Authors:  Mohapradeep Mohan; Adel Dihoum; Ify R Mordi; Anna-Maria Choy; Graham Rena; Chim C Lang
Journal:  Front Cardiovasc Med       Date:  2021-09-29

3.  Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy.

Authors:  Jan Stassen; Xavier Galloo; Surenjav Chimed; Kensuke Hirasawa; Nina Ajmone Marsan; Victoria Delgado; Pieter van der Bijl; Jeroen J Bax
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-06-01       Impact factor: 9.130
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.